Avalo Therapeutics Inc
F:C6K0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K0
|
US |
|
S
|
Sonic Healthcare Ltd
SWB:SAB
|
AU |
|
D
|
Dollarama Inc
XBER:DR3
|
CA |
|
Majestic Gold Corp
OTC:MJGCF
|
CA |
|
GSS Infotech Ltd
NSE:GSS
|
IN |
|
Esprinet SpA
MIL:PRT
|
IT |
|
C
|
CITIC Securities Co Ltd
OTC:CIIHF
|
CN |
|
Mastercraft Boat Holdings Inc
NASDAQ:MCFT
|
US |
|
Kko International SA
F:5KI1
|
BE |
|
Oil and Natural Gas Corporation Ltd
NSE:ONGC
|
IN |
|
Kirkland's Inc
NASDAQ:TBHC
|
US |
|
Brookfield Business Corp
F:C6E
|
US |
|
C
|
China Coal Energy Co Ltd
XHAM:CVV
|
CN |
|
EDM Resources Inc
OTC:EDMFF
|
CA |
|
B
|
Boosh Plant Based Brands Inc
CNSX:VEGI
|
CA |
|
F
|
FACC AG
F:1FC
|
AT |
Bankruptcy Probability
Avalo Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Avalo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
969.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
458.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Avalo Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Avalo Therapeutics Inc has total debt of 2m USD. This includes both short-term (0 USD) and long-term (2m USD) debt.
You can find a full breakdown on its Balance Sheet.
